Urgent-start dialysis in patients referred early to a nephrologist—the CKD-REIN prospective cohort study
Victor Fages(Université de Lille), Mustafa Smati, Denis Fouque(Université Claude Bernard Lyon 1), Bruno Moulin(Université de Strasbourg), Éric Magnant, Thierry Lobbedez, Thierry Hannedouche, Karine Legrand(Centre Hospitalier Universitaire Amiens-Picardie), Bruce Robinson(University of Michigan), Marie Metzger, Sébastien Mailliez, Carole Ayav(Inserm), Sophie Liabeuf(Centre Hospitalier Universitaire Amiens-Picardie), Christian Jacquelinet(Université Paris-Sud), Dorothée Cannet, Jean Philippe Bourdenx, Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Yves-Édouard Herpe, Gaëtan Lebrun(Assistance Publique – Hôpitaux de Paris), Gabriel Choukroun(Centre Hospitalier Universitaire Amiens-Picardie), Hacène Sekhri, Benjamin Deroure, Bénédicte Stengel(Inserm), Élodie Speyer, Adeline Lacraz(Centre Hospitalier Universitaire de Bordeaux), Luc Frimat(Centre Hospitalier Régional et Universitaire de Nancy), Aghilès Hamroun(Université de Lille), Marie Essig, Natália Alencar de Pinho(Inserm), Christophe Pascal, Raymond Azar, Maurice Laville(Lyon 1 Université), Serge Briançon, Céline Lange, G Lambrey, Julie Boucquemont(Inserm), Christian Combe(Université de Bordeaux)
Cited by 16
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766